Hepatitis B Virus Program

About Ai-Biopharma

Ai-Biopharma is a Paris-based, AI-driven drug discovery company operating a dual business model of providing computational chemistry services and developing its own therapeutic assets. Founded by seasoned pharmaceutical industry veterans, the company combines deep medicinal chemistry expertise in antiviral and nucleoside chemistry with a proprietary AI platform for drug design and optimization. Its primary focus is on accelerating the identification and optimization of preclinical candidates, with internal programs targeting viral diseases. The company appears to be a privately held, preclinical-stage entity.

Therapeutic Areas

Other Hepatitis B Drugs